Aggreko shares jump as HSBC upgrades the stock to 'buy'

HSBC upgraded Aggreko to ‘buy’ from ‘hold’ and raised its target price to 1,050p from 740p.

Aggreko's shares rose 4.9% in late morning trading

Aggreko PLC (LON:AGK) shares jumped after HSBC Global Research turned positive on the temporary generator specialist, saying it sees high risk but high reward on the stock.

HSBC upgraded Aggreko to ‘buy’ from ‘hold’ and raised its target price to 1,050p from 740p.

Earlier this month the company said it was on track to meet full year earnings expectations despite a 7% decline in pre-tax profit to £59mln in the first half due to higher fuel costs.

Revenues increased 14% to £857mln, with the rental solutions business (up 32%) leading the way. 

READ: Aggreko confident on hitting full-year numbers after "encouraging" first half 

Aggreko said it was confident it can deliver a return on capital employed “in the mid-teens in 2020 with potential for further improvement beyond this”. The company is in the middle of a restructuring and plans cost cuts of £50mln to improve profitability in the medium term.

“We think that much of Aggreko’s woes are of a cyclical nature, rather than structural,” HSBC said.

“The supply chain is supportive of expecting such a recovery, bar the risks from a trade war led disruption. If we are right, growth will return.”

HSBC said it expects a late cyclical improvement in the underlying business.

“If Aggreko moves from its current unloved status to the ‘new management turnaround of a fallen angel’ story, we expect the upside to be attractive,” HSBC said.

The bank said key risks include trade wars that may impair cyclical growth and receivables collection pace, along with contract churn, led by underinvestment.

Shares rose 4.9% to 884p in late morning trading. 

Quick facts: Aggreko

Price: 517.5 GBX

Market: LSE
Market Cap: £1.33 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Second coronavirus wave inevitable believes BB Healthcare Trust PLC's Paul Major

BB Healthcare Trust’s (LON:BBH) Paul Major believes a second wave of coronavirus infections is inevitable and he is positioning the trust’s portfolio accordingly. The view that it is sunny uplands for equity markets from here is slightly disconcerting, he told Proactive, even with the recent...

8 hours, 22 minutes ago

2 min read